M. Moreno

Hospital Clínico San Carlos — Spain

Medicine · Health Sciences

17h-index1.4kcitations59works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dementia and Cognitive Impairment Research(13), Alzheimer's disease research and treatments(11), Long-Term Effects of COVID-19(8), COVID-19 and Mental Health(7), Crystallization and Solubility Studies(7)

Publications55 total

IMAS, Unique TB-PET System with DOI and TOF: First Clinical Tests
2025
Documento de consenso de la Sociedad Española de Neurologia sobre prevención del deterioro cognitivo y la demencia
Neurología·2025Open Access
Impact of COPD and dynapenia on the prognosis of Right Heart Failure
2025
Gestión Urbana en el Departamento del Meta
Corporación Universitaria del Meta - UNIMETA eBooks·2025
257 | ZANUBRUTINIB IN RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (R/R MZL): EFFICACY AND SAFETY OF 101 SPANISH PATIENTS TREATED IN THE REAL‐WORLD ON BEHALF OF GELTAMO
Hematological Oncology·2025Open Access
P-12 METHYL GROUP DONOR SUPPLEMENTATION IN A MetALD MODEL: REGULATION OF GUT MICROBIOTA AND METABOLIC PARAMETERS
Annals of Hepatology·2024Open Access
Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort
Alzheimer s Research & Therapy·2024· 5 citedOpen Access
Profile of Inflammatory Biomarkers in Hodgkin Lymphoma. Differences between HIV-Negative and HIV-Positive Patients
Blood·2024· 3 cited
The Addition of Brentuximab Vedotin to ESHAP Significantly Increases the Rate of Metabolic Complete Remissions Vs Chemotherapy Alone. in Patients with Relapsed/Refractory Classical Hodgkin's Lymphoma. Final Results of a Phase IIb Prospective Randomized Clinical Trial (BRESELIBET)
Blood·2024· 3 cited
In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
Translational Neurodegeneration·2024· 26 citedOpen Access
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort
Alzheimer s Research & Therapy·2024· 10 citedOpen Access
Translating NIA‐AA criteria into usual practice: Report from the ReDeMa Project
Alzheimer s & Dementia Translational Research & Clinical Interventions·2024· 5 citedOpen Access
PROGNOSTIC VALUE OF AT(N) CLASSIFICATION IN CSF USING CLUSTERING ANALYSIS
Alzheimer s & Dementia·2023Open Access
Unraveling brain fog in <scp>post‐COVID</scp> syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms
European Journal of Neurology·2023· 31 citedOpen Access
A data‐driven approach to complement the A/T/(N) classification system using CSF biomarkers
CNS Neuroscience & Therapeutics·2023· 4 citedOpen Access
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline
Alzheimer s Research & Therapy·2023· 38 citedOpen Access
Neural basis of visuospatial tests in behavioral variant frontotemporal dementia
Frontiers in Aging Neuroscience·2022· 7 citedOpen Access
Validation of a brief cross-cultural cognitive screening test in Multiple Sclerosis
Multiple Sclerosis and Related Disorders·2022· 6 cited
Neuropsychological Predictors of Fatigue in Post-COVID Syndrome
Journal of Clinical Medicine·2022· 25 citedOpen Access
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Biomedicines·2022· 32 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Itziar de Rojas(14), Jordi A. Matías‐Guiu(14), Jorge Matías‐Guiu(13), Montserrat Alegret(12), Ana Espinosa(12), Gemma Ortega(12), Merçé Boada(12), Alfonso Delgado‐Álvarez(12), Maitée Rosende‐Roca(11), Ángela Sanabria(11), Alba Pérez‐Cordón(11), Pilar Cañabate(11), Óscar Sotolongo‐Grau(11), Adelina Orellana(11), Laura Montrreal(10), Liliana Vargas(10), Sílvia Preckler(10), S. Diego(10), M. Guitart(10), Marta Ibarria(10)